Cargando…

Discovery of Potent and Selective CB2 Agonists Utilizing a Function-Based Computational Screening Protocol

[Image: see text] Nowadays, the identification of agonists and antagonists represents a great challenge in computer-aided drug design. In this work, we developed a computational protocol enabling us to design/screen novel chemicals that are likely to serve as selective CB2 agonists. The principle of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ge, Haixia, Ji, Beihong, Fang, Jiahui, Wang, Jiayang, Li, Jing, Wang, Junmei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2023
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10623575/ https://www.ncbi.nlm.nih.gov/pubmed/37823773 http://dx.doi.org/10.1021/acschemneuro.3c00580

Ejemplares similares

Structure-based discovery of potent and selective melatonin receptor agonists
por: Patel, Nilkanth, et al.
Publicado: (2020)

Selective Estrogen Receptor Modulators: Cannabinoid Receptor Inverse Agonists with Differential CB1 and CB2 Selectivity
por: Franks, Lirit N., et al.
Publicado: (2016)

The discovery of a selective and potent A(2a) agonist with extended lung retention
por: Åstrand, Annika B M, et al.
Publicado: (2015)

Insights on FXR selective modulation. Speculation on bile acid chemical space in the discovery of potent and selective agonists
por: Sepe, Valentina, et al.
Publicado: (2016)

Computational Prediction and Biochemical Analyses of New Inverse Agonists for the CB1 Receptor
por: Scott, Caitlin E., et al.
Publicado: (2015)

Discovery of TAK-925 as a Potent, Selective, and Brain-Penetrant Orexin 2 Receptor Agonist
por: Fujimoto, Tatsuhiko, et al.
Publicado: (2022)

Discovery of Highly Potent Liver X Receptor β Agonists
por: Kick, Ellen K., et al.
Publicado: (2016)

Discovery of Kynurenines Containing Oligopeptides as Potent Opioid Receptor Agonists
por: Szűcs, Edina, et al.
Publicado: (2020)

Discovery of Paltusotine (CRN00808), a Potent, Selective, and Orally Bioavailable Non-peptide SST2 Agonist
por: Zhao, Jian, et al.
Publicado: (2022)

Discovery of a novel potent peptide agonist to adiponectin receptor 1
por: Kim, Sunghwan, et al.
Publicado: (2018)

Time-Dependent Protection of CB2 Receptor Agonist in Stroke
por: Yu, Seong-Jin, et al.
Publicado: (2015)

Cannabinoid CB1 and CB2 Receptor-Mediated Arrestin Translocation: Species, Subtype, and Agonist-Dependence
por: Ibsen, Mikkel Søes, et al.
Publicado: (2019)

Positive Allosteric Modulation of CB1 and CB2 Cannabinoid Receptors Enhances the Neuroprotective Activity of a Dual CB1R/CB2R Orthosteric Agonist
por: Polini, Beatrice, et al.
Publicado: (2020)

Anti-inflammatory and antinociceptive effects of the selective cannabinoid CB(2) receptor agonist ABK5
por: Tang, Yaliang, et al.
Publicado: (2020)

Characterization of Subtype Selective Cannabinoid CB(2) Receptor Agonists as Potential Anti-Inflammatory Agents
por: Tang, Yaliang, et al.
Publicado: (2021)

Discovery and lead optimisation of a potent, selective and orally bioavailable RARβ agonist for the potential treatment of nerve injury
por: Goncalves, Maria B., et al.
Publicado: (2019)

Discovery of CVN636: A Highly Potent, Selective, and CNS Penetrant mGluR(7) Allosteric Agonist
por: Dickson, Louise, et al.
Publicado: (2023)

Evaluation of carboxamide-type synthetic cannabinoids as CB(1)/CB(2) receptor agonists: difference between the enantiomers
por: Doi, Takahiro, et al.
Publicado: (2017)

Effects of a CB(2) Subtype Selective Agonist ABK5-1 on Cytokine Production in Microglia
por: Tang, Yaliang, et al.
Publicado: (2021)

Cannabinoid CB1 receptor agonist ACEA alleviates brain ischemia/reperfusion injury via CB1–Drp1 pathway
por: Yang, Shuai, et al.
Publicado: (2020)

Discovery and biological evaluation of a diphenethylamine derivative (HS665), a highly potent and selective κ opioid receptor agonist
por: Spetea, Mariana, et al.
Publicado: (2012)

EVs-mediated delivery of CB2 receptor agonist for Alzheimer's disease therapy
por: Zhu, Yanjing, et al.
Publicado: (2023)

Pharmacological Properties, Therapeutic Potential and Molecular Mechanisms of JWH133, a CB2 Receptor-Selective Agonist
por: Hashiesh, Hebaallah Mamdouh, et al.
Publicado: (2021)

Vascular Dysfunction in a Transgenic Model of Alzheimer's Disease: Effects of CB1R and CB2R Cannabinoid Agonists
por: Navarro-Dorado, Jorge, et al.
Publicado: (2016)

Licraside as novel potent FXR agonist for relieving cholestasis: structure-based drug discovery and biological evaluation studies
por: Xi, Lili, et al.
Publicado: (2023)

Discovery of Potent Glucokinase and PPARγ Dual-Target Agonists through an Innovative Scheme for Regioselective Modification of Silybin
por: Zhang, Zhipeng, et al.
Publicado: (2022)

Discovery of Homobivalent Bitopic Ligands of the Cannabinoid CB(2) Receptor
por: Morales, Paula, et al.
Publicado: (2020)

Effects of a Selective Cannabinoid CB2 Agonist and Antagonist on Intravenous Nicotine Self Administration and Reinstatement of Nicotine Seeking
por: Gamaleddin, Islam, et al.
Publicado: (2012)

Anti-Proliferative Properties and Proapoptotic Function of New CB2 Selective Cannabinoid Receptor Agonist in Jurkat Leukemia Cells
por: Capozzi, Antonella, et al.
Publicado: (2018)

Synthesis and In Vitro Characterization of Selective Cannabinoid CB2 Receptor Agonists: Biological Evaluation against Neuroblastoma Cancer Cells
por: Gado, Francesca, et al.
Publicado: (2022)

High-resolution crystal structure of the human CB1 cannabinoid receptor
por: Shao, Zhenhua, et al.
Publicado: (2016)

In Silico Screen Identifies a New Family of Agonists for the Bacterial Mechanosensitive Channel MscL
por: Wray, Robin, et al.
Publicado: (2022)

Discovery of SHR9352: A Highly Potent G Protein-Biased μ-Opioid Receptor Agonist
por: Li, Xin, et al.
Publicado: (2017)

Unanticipated Characteristics of a Selective, Potent Neuromedin-U Receptor 2 Agonist
por: Mehrotra, Suneet, et al.
Publicado: (2022)

Taipan Natriuretic Peptides Are Potent and Selective Agonists for the Natriuretic Peptide Receptor A
por: Vink, Simone, et al.
Publicado: (2023)

Exploring determinants of agonist efficacy at the CB1 cannabinoid receptor: Analogues of the synthetic cannabinoid receptor agonist EG‐018
por: Finlay, David B., et al.
Publicado: (2022)

Anti-Inflammatory Activity of a CB2 Selective Cannabinoid Receptor Agonist: Signaling and Cytokines Release in Blood Mononuclear Cells
por: Capozzi, Antonella, et al.
Publicado: (2021)

Discovery of 7-Azanorbornane-Based Dual Agonists for the Delta and Kappa Opioid Receptors through an In Situ Screening Protocol
por: Karaki, Fumika, et al.
Publicado: (2023)

Discovery of Natural Products as Novel and Potent FXR Antagonists by Virtual Screening
por: Diao, Yanyan, et al.
Publicado: (2018)

Targeting Bile Acid Receptors: Discovery of a Potent and Selective Farnesoid X Receptor Agonist as a New Lead in the Pharmacological Approach to Liver Diseases
por: Festa, Carmen, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_aidsshlki6vrmpujkjmhtk6tvm